Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials

BACKGROUND: This aim of this study was to compare the efficacy of first-line tyrosine kinase inhibitor therapy followed, upon progression, by chemotherapy with the reverse sequence in patients with EGFR-mutated non-small cell lung cancer (NSCLC) in terms of overall survival. METHODS: We performed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yiliang, Sun, Yihua, Wang, Lei, Ye, Ting, Pan, Yunjian, Hu, Haichuan, Yu, Yongfu, Zhao, Naiqing, Song, Yanyan, Garfield, David, Chen, Haiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848930/
https://www.ncbi.nlm.nih.gov/pubmed/24348052
http://dx.doi.org/10.2147/OTT.S54502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848930/
https://www.ncbi.nlm.nih.gov/pubmed/24348052
http://dx.doi.org/10.2147/OTT.S54502

Ejemplares similares